Opportunity Information: Apply for PAR 18 555

Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) is a National Institutes of Health (NIH) research funding opportunity (PAR-18-555) aimed at advancing what is sometimes called the "systems-level timing" view of brain function. The central idea behind the announcement is that many core human capacities, including cognition (such as attention, learning, working memory, and decision-making), affect (emotion and mood regulation), and social behavior, tend to work best when activity across brain regions is tightly coordinated in time. This coordination can show up as oscillatory rhythms (brain waves), interactions between different frequency bands (cross-frequency coupling), relationships between neuronal spiking and ongoing rhythms (spike-phase coupling), and broader population-level patterns of activity across networks. Because many neuropsychiatric disorders involve disruptions in these coordinated dynamics, the FOA encourages projects that directly test whether changing these electrophysiological patterns during behavior can produce measurable improvements in cognitive, emotional, or social functioning.

A key emphasis of this opportunity is active manipulation rather than purely observational measurement. The NIH is looking for experimental designs where investigators do something that perturbs, drives, or modifies neural coordination and then evaluates causal effects on behavior and relevant outcomes. That manipulation could be done in animals or humans, and the announcement leaves room for clinical trials but does not require them (the FOA is labeled "Clinical Trial Optional"). The broader translational motivation is to identify actionable neural dynamics that could eventually serve as targets for interventions that treat symptoms common across neuropsychiatric conditions, especially symptoms related to cognition, social processing, or affect.

Applications must address at least one of four main scientific directions, and the FOA makes clear that stronger applications may integrate more than one. First, applicants can focus on identifying which specific parameters of neural coordination matter for particular behavioral functions, and whether manipulating those parameters in isolation improves performance. In practice, this could mean systematically testing features like phase synchrony, oscillation frequency or amplitude, timing relationships between regions, or specific coupling patterns, and then linking those manipulations to discrete improvements in attention, memory, emotional reactivity, or social perception. The emphasis on "in isolation" signals interest in careful experimental control, where a project tries to pinpoint the functional role of a defined coordination feature rather than broadly stimulating or suppressing large portions of the brain without mechanistic clarity.

Second, the FOA invites work that bridges biological mechanisms across scales by asking how abnormalities at the genomic, molecular, or cellular levels impact systems-level coordination during behavior. This direction is designed for projects that connect risk factors or disease-relevant perturbations (for example, genetic variants, altered neurotransmission, circuit-level inhibitory/excitatory balance changes, or cell-type-specific dysfunction) to measurable changes in network timing and coordination. The practical payoff is a clearer account of how underlying pathophysiology produces network-level timing disruptions, which can sharpen both mechanistic understanding and intervention strategies.

Third, the opportunity supports translational alignment between animal and human work by encouraging studies that test whether systems-level electrophysiological changes observed in behaving animals can predict analogous electrophysiological and cognitive improvements in healthy humans or clinical populations. In other words, the NIH is not only interested in finding an effect in an animal model; it also wants applicants to consider whether the same kind of timing-based neural signature can be measured and moved in humans in a way that tracks with meaningful cognitive or behavioral gains. This direction supports the development of cross-species biomarkers and intervention targets that are more likely to generalize from preclinical findings to clinical impact.

Fourth, the FOA highlights the role of biologically realistic computational modeling, specifically models that incorporate systems-level aspects of brain function. The focus here is not abstract modeling divorced from biology, but models grounded in realistic neural dynamics that can help explain how oscillations and other temporal coordination patterns emerge, propagate across circuits, and influence cognition, affect, or social behavior. This direction supports projects where modeling is used to generate mechanistic hypotheses, interpret complex multiregion recordings, predict the outcomes of specific manipulations, or optimize intervention parameters for driving beneficial coordination patterns.

From a funding structure standpoint, this is an R01 opportunity, which generally supports larger, longer-term, hypothesis-driven projects compared with exploratory mechanisms. The FOA notes that there is a companion R21 announcement aimed at shorter, potentially higher-risk exploratory work, while PAR-18-555 is the R01 pathway for more developed research programs. The activity category is Health, and the CFDA number listed is 93.242. The funding instrument is a grant, and the opportunity is categorized as discretionary.

Eligibility is broad and includes many types of institutions and organizations. Standard eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; and nonprofits both with and without 501(c)(3) status (as long as they are not institutions of higher education, depending on category). The FOA also allows for-profit organizations (other than small businesses) and small businesses, as well as other categories. In addition, it explicitly calls out a wide range of other eligible applicants, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also includes faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations), reflecting an intent to broaden participation and leverage diverse research settings and populations.

Finally, the administrative details provided in the source indicate the opportunity was created on January 2, 2018, with an original closing date listed as March 5, 2021. The award ceiling and expected awards fields are not specified in the provided excerpt, so applicants would typically look to NIH budget guidance for R01s and any FOA-specific budget instructions in the full notice. Overall, the announcement is best understood as a targeted call for causal, mechanistically grounded studies that treat coordinated neural timing patterns not just as correlates of healthy brain function, but as modifiable levers that can be tuned to improve cognitive, affective, and social outcomes in both basic and translational contexts.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) and Clinical Trial Optional" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2018-01-02.
  • Applicants must submit their applications by 2021-03-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 555

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) (PAR-18-555)

What is this funding opportunity?

This opportunity is an NIH research grant funding announcement titled "Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01)" with FOA number PAR-18-555. It supports research on systems-level timing in brain function, with a focus on coordinated neural activity across brain regions.

Which NIH grant mechanism does this use?

It is an R01 opportunity, which typically supports larger, longer-term, hypothesis-driven research projects compared with exploratory mechanisms.

What is the main scientific focus of PAR-18-555?

The central focus is on "systems-level timing" in the brain: how tightly coordinated neural activity across brain regions supports cognition (attention, learning, working memory, decision-making), affect (emotion and mood regulation), and social behavior, and how manipulating those coordinated dynamics can change behavioral outcomes.

What kinds of neural coordination patterns are relevant to this FOA?

The FOA highlights multiple temporal coordination phenomena, including oscillatory rhythms (brain waves), cross-frequency coupling (interactions between frequency bands), spike-phase coupling (relationships between neuronal spiking and ongoing rhythms), and broader population-level coordinated activity patterns across networks.

Why is NIH interested in coordinated neural timing for mental health research?

The FOA emphasizes that many neuropsychiatric disorders involve disruptions in coordinated neural dynamics. The translational motivation is to identify modifiable, actionable neural dynamics that could become intervention targets for symptoms that cut across conditions, especially cognitive, social, and affect-related symptoms.

Is the FOA focused on observation or manipulation?

The FOA places a key emphasis on active manipulation rather than purely observational measurement. Projects are expected to perturb, drive, or modify neural coordination during behavior and test causal effects on behavior and relevant outcomes.

Do projects need to involve humans, animals, or both?

The FOA allows manipulation studies in animals or humans. It also encourages translational alignment between animal and human work, but does not state that both are required for every application.

Are clinical trials required?

No. The FOA is labeled "Clinical Trial Optional," meaning clinical trials are allowed but not required based on the information provided.

What is meant by treating neural dynamics as "modifiable levers"?

In this FOA, coordinated temporal patterns are not treated only as correlates of healthy function. Instead, applicants are encouraged to test whether deliberately changing specific electrophysiological coordination patterns during behavior can produce measurable improvements in cognition, affect, or social functioning.

What are the main scientific directions applications must address?

Applications must address at least one of four scientific directions described in the FOA. The FOA notes that stronger applications may integrate more than one direction.

What is Direction 1 about (specific parameters of coordination)?

Direction 1 focuses on identifying which specific parameters of neural coordination matter for particular behavioral functions and testing whether manipulating those parameters in isolation improves performance. Examples of parameters include phase synchrony, oscillation frequency or amplitude, timing relationships between regions, and specific coupling patterns.

What does "in isolation" imply for Direction 1 studies?

It signals interest in careful experimental control and mechanistic clarity: isolating a defined coordination feature to pinpoint its functional role, rather than broadly stimulating or suppressing large parts of the brain without a clear mechanism.

What is Direction 2 about (bridging mechanisms across scales)?

Direction 2 supports work linking genomic, molecular, or cellular abnormalities to systems-level coordination changes during behavior. The goal is to connect disease-relevant perturbations (such as genetic variants, altered neurotransmission, inhibitory/excitatory balance changes, or cell-type-specific dysfunction) to measurable changes in network timing and coordination.

What is Direction 3 about (animal-to-human translational alignment)?

Direction 3 encourages studies testing whether systems-level electrophysiological changes observed in behaving animals can predict analogous electrophysiological and cognitive improvements in healthy humans or clinical populations. This supports development of cross-species biomarkers and intervention targets likely to generalize from preclinical research to clinical impact.

What is Direction 4 about (computational modeling)?

Direction 4 highlights biologically realistic computational modeling that incorporates systems-level brain function. These models should be grounded in realistic neural dynamics and can be used to generate mechanistic hypotheses, interpret multiregion recordings, predict outcomes of specific manipulations, or optimize intervention parameters for driving beneficial coordination patterns.

Does the FOA encourage combining multiple directions?

Yes. While applications must address at least one direction, the FOA indicates that stronger applications may integrate more than one of the four directions.

What kinds of outcomes does NIH want investigators to evaluate?

The FOA emphasizes measurable improvements in cognitive, emotional, or social functioning, tied causally to experimental manipulation of coordinated electrophysiological patterns during behavior.

How is this R01 related to other NIH opportunities mentioned?

The FOA notes there is a companion R21 announcement aimed at shorter, potentially higher-risk exploratory work. PAR-18-555 is presented as the R01 pathway for more developed research programs.

What is the funding instrument and opportunity category?

The funding instrument is a grant, and the opportunity is categorized as discretionary based on the provided information.

What is the activity category and CFDA number?

The activity category is Health, and the CFDA number listed is 93.242.

Who is eligible to apply?

Eligibility is broad and includes many institutions and organizations, including state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; tribal governments and tribal organizations (including those not federally recognized); public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (as categorized); for-profit organizations (other than small businesses); small businesses; and other categories named in the FOA excerpt.

Does the FOA explicitly encourage applications from certain institution types?

Yes. It explicitly calls out HBCUs, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and AANAPISIs among eligible applicants.

Are faith-based or community-based organizations eligible?

Yes. The eligibility list in the provided information includes faith-based or community-based organizations.

Are federal agencies eligible applicants?

Yes. The provided eligibility list includes eligible federal agencies.

Can non-U.S. (foreign) organizations apply?

Yes. The eligibility list includes non-U.S. entities (foreign organizations).

Are U.S. territories or possessions included?

Yes. The eligibility list includes U.S. territories or possessions.

When was this opportunity created, and what closing date is listed?

The administrative details provided indicate it was created on January 2, 2018, and an original closing date listed is March 5, 2021.

Is the award ceiling or number of expected awards provided?

No. The provided excerpt states that the award ceiling and expected awards fields are not specified.

Where would applicants typically look for budget guidance for an R01 under this FOA?

Based on the provided information, applicants would typically look to NIH budget guidance for R01s and any FOA-specific budget instructions in the full notice, since the excerpt does not specify an award ceiling.

What makes a strong application under this FOA, based on the description?

A strong application is described as one that is causal and mechanistically grounded, focuses on active manipulation of coordinated neural timing patterns during behavior, evaluates measurable behavioral outcomes (cognitive, affective, social), and may integrate multiple scientific directions (parameter isolation, cross-scale biology, cross-species translation, and biologically realistic computational modeling).

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: FY 2018 Future Leaders Exchange (FLEX) Program Organizational Components

Previous opportunity: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 555

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 555) also looked into and applied for these:

Funding Opportunity
Tanzania Malaria Surveillance and Monitoring (TMSM) Apply for SOL72062118RFA00001

Funding Number: SOL72062118RFA00001
Agency: Tanzania USAID-Dar es Salaam
Category: Health
Funding Amount: $14,100,000
Hearing Health Care for Adults: Improving Access and Affordability (R01 Clinical Trial Optional) Apply for PA 18 438

Funding Number: PA 18 438
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required) Apply for PAR 18 435

Funding Number: PAR 18 435
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 - No Independent Clinical Trials) Apply for PAR 18 436

Funding Number: PAR 18 436
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Competing Renewal Awards of SBIR Phase IIB Grants for Brain and Behavior Tools (R44 Clinical Trial Optional) Apply for PA 18 567

Funding Number: PA 18 567
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01 - Clinical Trial Optional) Apply for PAR 18 561

Funding Number: PAR 18 561
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Hearing Health Care for Adults: Improving Access and Affordability (R21 Clinical Trial Optional) Apply for PA 18 382

Funding Number: PA 18 382
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44 - Clinical Trials Optional) Apply for PAR 18 563

Funding Number: PAR 18 563
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Research Career Enhancement Award for Established Investigators (K18 -Clinical Trials Required) Apply for PAR 18 562

Funding Number: PAR 18 562
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Research Career Enhancement Award for Established Investigators (K18 - No Independent Clinical Trials) Apply for PAR 18 564

Funding Number: PAR 18 564
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Lab to Marketplace: Tools for Brain and Behavioral Research (R43/R44 - Clinical Trial Optional Apply for PAR 18 565

Funding Number: PAR 18 565
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional) Apply for PA 18 572

Funding Number: PA 18 572
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional) Apply for PA 18 571

Funding Number: PA 18 571
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44 Clinical Trial Optional) Apply for PA 18 566

Funding Number: PA 18 566
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 -Clinical Trial Optional) Apply for PAR 18 580

Funding Number: PAR 18 580
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Emotional Function in Normal Aging and/or MCI and AD/ADRD (R01 - Clinical Trial Optional) Apply for PAR 18 581

Funding Number: PAR 18 581
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Emotional Function in Normal Aging and/or MCI and AD/ADRD (R21 - Clinical Trial Not Allowed) Apply for PAR 18 582

Funding Number: PAR 18 582
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional) Apply for PAR 18 578

Funding Number: PAR 18 578
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trials Not Allowed) Apply for PAR 18 577

Funding Number: PAR 18 577
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42) Apply for PA 18 579

Funding Number: PA 18 579
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 555", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: